West Family Investments Inc. Increases Position in Intuitive Surgical, Inc. $ISRG

by · The Cerbat Gem

West Family Investments Inc. grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 39.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,297 shares of the medical equipment provider’s stock after buying an additional 366 shares during the quarter. West Family Investments Inc.’s holdings in Intuitive Surgical were worth $705,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in ISRG. Aaron Wealth Advisors LLC lifted its holdings in Intuitive Surgical by 0.8% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after buying an additional 19 shares during the last quarter. Exencial Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 3.1% in the 1st quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock valued at $327,000 after acquiring an additional 20 shares during the last quarter. Evergreen Capital Management LLC raised its position in shares of Intuitive Surgical by 0.5% during the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after acquiring an additional 20 shares in the last quarter. Rise Advisors LLC lifted its stake in Intuitive Surgical by 5.6% during the first quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after purchasing an additional 20 shares during the last quarter. Finally, Pinnacle Bancorp Inc. lifted its stake in Intuitive Surgical by 4.1% during the second quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock worth $289,000 after purchasing an additional 21 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.2%

NASDAQ ISRG opened at $573.32 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The stock’s 50-day moving average price is $505.94 and its two-hundred day moving average price is $505.05. The company has a market cap of $205.52 billion, a PE ratio of 75.84, a PEG ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the prior year, the business earned $1.84 EPS. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Truist Financial set a $620.00 target price on shares of Intuitive Surgical and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Daiwa Capital Markets increased their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Mizuho set a $575.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Wells Fargo & Company lifted their target price on Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Finally, Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

Read Our Latest Report on Intuitive Surgical

Insider Activity at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 3,500 shares of the business’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the transaction, the executive vice president owned 5,758 shares of the company’s stock, valued at approximately $3,310,850. The trade was a 37.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gary S. Guthart sold 28,800 shares of the stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.56, for a total transaction of $15,769,728.00. Following the completion of the sale, the insider directly owned 27,027 shares of the company’s stock, valued at approximately $14,798,904.12. This trade represents a 51.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 86,804 shares of company stock valued at $48,043,866. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles